Leptin and Serum Erythropoietin in Hemodialyzed and Peritoneally Dialyzed Uremic Patients during rHuEPO Therapy
暂无分享,去创建一个
[1] F. Lönnqvist,et al. Peritoneal clearance of leptin in CAPD patients: impact of local insulin administration. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] N. Haran,et al. Leptin in CAPD patients: serum concentrations and peritoneal loss. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[3] S. Klein,et al. High-flux dialysis lowers plasma leptin concentration in chronic dialysis patients. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[4] V. Carreño,et al. Role of cytokines in the response to erythropoietin in hemodialysis patients. , 1998, Kidney international.
[5] F. Lönnqvist,et al. Low leptin gene expression and hyperleptinemia in chronic renal failure. , 1998, Kidney international.
[6] M. Laville,et al. Acute leptin regulation in end-stage renal failure: the role of growth hormone and IGF-1. , 1998, Kidney international.
[7] P. Kimmel,et al. Immunologic function and survival in hemodialysis patients. , 1998, Kidney international.
[8] A. Więcek,et al. Influence of long-term recombinant human erythropoietin (rHuEpo) therapy on plasma leptin and neuropeptide Y concentration in haemodialysed uraemic patients. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[9] F. Lönnqvist,et al. Does the ob gene product leptin stimulate erythropoiesis in patients with chronic renal failure? , 1998, Kidney international.
[10] G M Steil,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Diurnal and Ultradian Rhythmicity of Plasma Leptin: Effects of Gender and Adiposity* , 2022 .
[11] F. Lönnqvist,et al. Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. , 1997, Journal of the American Society of Nephrology : JASN.
[12] R. Darnell,et al. Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[13] K. Sharma,et al. Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. , 1997, Kidney international.
[14] F. Valderrábano,et al. Erythropoietin in chronic renal failure. , 1996, Kidney international.
[15] B. Bennett,et al. A role for leptin and its cognate receptor in hematopoiesis , 1996, Current Biology.
[16] S. Klein,et al. Radioimmunoassay of leptin in human plasma. , 1996, Clinical chemistry.
[17] A. Mikhail,et al. Novel B219/OB receptor isoforms: Possible role of leptin in hematopoiesis and reproduction , 1996, Nature Medicine.
[18] J. Friedman,et al. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. , 1996, The Journal of clinical investigation.
[19] P. Bárány. Endocrinology and Pd: Optimal Treatment of Anemia in Peritoneal Dialysis Patients , 1996, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[20] I. Macdougall,et al. Poor response to erythropoietin: practical guidelines on investigation and management. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[21] M. Maffei,et al. Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.
[22] N. Levin. Quality of life and hematocrit level. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[23] H. Snodgrass,et al. Leptin stimulates fetal and adult erythroid and myeloid development. , 1997, Blood.
[24] J. Chanard,et al. Cuprophane but not synthetic membrane induces increases in serum tumor necrosis factor-alpha levels during hemodialysis. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.